Skip to main content

Advertisement

Table 1 Frequency and duration of reported side effects among infants of group A (N = 45) and group B (N = 45) of an ITN trial conducted in Burkina Faso

From: Safety of insecticide-treated mosquito nets for infants and their mothers: randomized controlled community trial in Burkina Faso

Reported side effects Week 1 Week 2–4 Week 1–18
Frequencya RR (95 % CI)a P-valuea Duration of symptom (Days) P-valuec Frequency RR (95 % CI) P- value Duration of symptom (Days) P-value Frequency RR (95 % CI) P-value Duration of symptom (Days) P-value
A B A B A B A B A B A B
Rhinitis 10 9 1.14 (0.37–3.60) 1.00 41 40 0.87 16 13 1.36 (0.51–3.64) 0.65 151 98 0.53 20 19 1.09 (0.44–2.74) 1.00 223 185 0.86
Cough 5 6 0.81 (0.18–3.50) 1.00 7 19 0.11 14 8 2.09 (0.70–6.51) 0.22 118 51 0.79 23 21 1.19 (0.48–2.96) 0.83 167 103 0.54
Skin eruption 3 5 0.57 (0.08–3.18) 0.71 16 20 0.47 6 6 1.00 (0.24–4.10) 1.00 29 31 0.94 10 7 1.55 (0.47–5.34) 0.59 38 56 0.26
Diarrhea 3 0 0.24 3 0 6 6 1.00 (0.24–4.10) 1.00 7 12 0.42 9 8 1.16 (0.35–3.86) 1.00 12 15 0.24
Conjunctivits 1 7 0.12 (0.002–1.05) 0.06 2 22 0.40 6 1 6.77 (0.76–318.28) 0.11 19 4 0.80 9 9 1.00 (0.31–3.23) 1.00 18 26 0.18
Vomiting 2 6 0.30 (0.03–1.84) 0.27 2 14 0.25 5 2 2.68 (0.41–29.42) 0.43 15 3 0.37 7 7 1.00 (0.27–3.70) 1.00 18 17 1.00
Anal fissure 1 0 1.00 1 0 1 0 1.00 2 0 4 1 4.29 (0.40–216.11) 0.36 19 1 0.50
Others 2 3 0.65 (0.05–6.01) 1.00 4 15 0.44 2 3 0.65 (0.05–6.03) 1.00 5 16 0.44 14 16 0.82 (0.31–2.15) 0.82 28 32 0.52
  1. Group A Infants protected from birth onwards
  2. Group B Infants protected from month six onwards
  3. RR risk ratio, CI confidence interval
  4. aNumber of infants with at least one episode of respective side effects
  5. bCalculated with Fisher’s test
  6. cCalculated with Wilcoxon test